Advertisements



Clovis Oncology stock surges 50% on positive late-stage cancer trial results

Clovis Oncology Inc. shares surged 50% in premarket trade Monday after the company said its late-stage trial for a cancer drug met its primary endpoint and.....»»

Category: topSource: marketwatchJun 19th, 2017

Here"s Why Clovis Oncology (CLVS) Stock Skyrocketed Today

Shares of Clovis Oncology (CLVS) opened more than 40% higher on Monday morning after the company announced positive results in a late-stage trial involving its Rubraca therapy--an outcome that could help widen the use of the drug and.....»»

Category: topSource: zacksJun 19th, 2017

Novocure Ltd. Stock Surges Nearly 50% After Positive Late-stage Trial Results In Brain Cancer

Novocure Ltd. shares surged 49.4% in morning trade Monday after the company said its late-stage clinical trial in newly diagnosed glioblastoma showed positive results......»»

Category: topSource: foxnewsApr 3rd, 2017

Novocure Ltd. stock surges nearly 50% after positive late-stage trial results in brain cancer

Novocure Ltd. shares surged 49.4% in morning trade Monday after the company said its late-stage clinical trial in newly diagnosed glioblastoma showed positive results. Novocure found that the two-.....»»

Category: topSource: marketwatchApr 3rd, 2017

What’s Next For Clovis Oncology?

Clovis Oncology has delivered big results in a much-waited late-stage clinical trial for its ovarian cancer drug. Is a takeover on the horizon?.....»»

Category: blogSource: barronsJun 19th, 2017

Clovis Oncology Surges on Clutch Late-Stage Ovarian Cancer Trial

Clovis Oncology saw its shares make a massive gain early on Monday after the company announced top-line data from its confirmatory Phase 3 trial of its treatment of ovarian cancer......»»

Category: blogSource: 247wallstJun 19th, 2017

UPDATE: TG Therapeutics stock rises 4% on positive late-stage cancer trial results

TG Therapeutics Inc. shares rose 3.7% in morning trade Monday after the company said a late-stage clinical trial for its TG-1101 with AbbVi.....»»

Category: topSource: marketwatchJun 5th, 2017

TG Therapeutics stock rises 17% on positive late-stage cancer trial results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 5th, 2017

Aerie Pharma stock surges 31% on positive late-stage trial results for glaucoma eye drops

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 24th, 2017

Aerie Pharma stock surges 32% on positive late-stage trial results for glaucoma eye drops

Aerie Pharmaceuticals Inc. shares surged as much as 32% in after hours trade Wednesday after the company said its eye drops intended for glaucoma had positive results in a late-stage clinical trial. If Aerie Pharma sees positive safe.....»»

Category: topSource: marketwatchMay 24th, 2017

Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson"s drug

Acorda Therapeutics Inc. shares surged 9.0% in early morning trade after the company said its drug showed an imp.....»»

Category: topSource: marketwatchFeb 9th, 2017

Acorda stock surges 13% after positive late-stage clinical trial results for Parkinson"s drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchFeb 9th, 2017

Bristol-Myers stock drops nearly 9% after Merck announces positive lung cancer drug results

Bristol-Myers Squibb shares dropped 8.7% in premarket trade on Monday after Merck & Co. announced positive mid/late-stage clinical trial results for its rival lung cancer drug over the weekend. Merck said its Keytruda, which treats advanced non-small-ce.....»»

Category: topSource: marketwatchOct 10th, 2016

Clovis Oncology"s stock soars 49% premarket after positive phase 3 trial results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 19th, 2017

Acorda stock surges 10% on positive late-stage Parkinson"s results

Acorda Therapeutics Inc. shares surged 10.5% in heavy morning trade Tuesday after the company presented positive late-stage data for its Parkinson's disease drug. The company plans.....»»

Category: topSource: marketwatchJun 6th, 2017

Acorda Therapeutics stock surges 10% on positive late-stage Parkinson"s results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 6th, 2017

UPDATE: Onconova Therapeutics stock surges 7% on positive mid-stage clinical trial results

Onconova Therapeutics Inc. stock surged 7% in morning trade Monday after the company said its drug had positive results in a mid-stage clinical trial for patients with higher-risk myelodysplastic syndromes, conditions that are considered a .....»»

Category: topSource: marketwatchJun 5th, 2017

Onconova Therapeutics stock surges 11.5% on positive mid-stage clinical trial results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 5th, 2017

Merck reports positive results for late-stage trial comparing its Keytruda against Bristol-Myers" Yervoy

Merck & Co. Inc. said premarket Friday that a late-stage clinical trial comparing its cancer drug Keytruda to Bristol-Myers Squibb's [: BMY] cancer drug Yervoy found patients on Keytruda had better results. The trial, which enrolled 834 pa.....»»

Category: topSource: marketwatchJun 2nd, 2017

Nektar Therapeutics" stock jumps after positive results of its pain treatment drug

Shares of Nektar Therapeutics soared 18% toward a six-month high in premarket trade Monday, after reporting positive results of a late-stage trial of its opioid analgesic. The company said a phase 3 trial of.....»»

Category: topSource: marketwatchMar 20th, 2017

AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO)

Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease prog.....»»

Category: topSource: insidermonkeyMar 16th, 2017